In addition, the current data show that IMQ treatment could produce the altered metabolism (i.e., sphingolipid signaling pathway, coronavirus disease—COVID-19, steroid degradation, and renin secretion) induced by skin microbiota. The gene discussed is REN; the disease is COVID-19.